PDCD1 and neoplasm: This result was attributed to the correlation between a high CD45RA+CD25+/CD4+ T cell ratio and severe AEs related to treatment discontinuation and tissue damage, leading to the inferior OS despite similar PFS, which is closely related to tumor regression by anti-PD-1 therapy.